Ramona Schlenker, Petra C Schwalie, Steffen Dettling, Tamara Huesser, Anja Irmisch, Marisa Mariani, Julia M Martínez Gómez, Alison Ribeiro, Florian Limani, Sylvia Herter, Emilio Yángüez, Sabine Hoves, Jitka Somandin, Juliane Siebourg-Polster, Tony Kam-Thong, Ines Grazina de Matos, Pablo Umana, Reinhard Dummer, Mitchell P Levesque, Marina Bacac
BACKGROUND: The treatment of melanoma, the deadliest form of skin cancer, has greatly benefited from immunotherapy. However, many patients do not show a durable response, which is only partially explained by known resistance mechanisms. METHODS: We performed single-cell RNA sequencing of tumor immune infiltrates and matched peripheral blood mononuclear cells of 22 checkpoint inhibitor (CPI)-naive stage III-IV metastatic melanoma patients. After sample collection, the same patients received CPI treatment, and their response was assessed...
April 4, 2024: Med